SCHEMBL25855521

SCHEMBL25855521

CC1CN(C2CCN(C3CC4(CCN(C(C)C)CC4)C3)CC2)C1

nearest known ligand 0.42

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 9/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24185875 0.92 HRH3 (0.38) HRH3
SCHEMBL24185421 0.91 HRH3 (0.44) HRH3
SCHEMBL24185176 0.89 HRH3 (0.36) HRH3
SCHEMBL24185425 0.89 HRH3 (0.39) HRH3
SCHEMBL24185179 0.88 HRH3 (0.40) HRH3
SCHEMBL24828016 0.84 HRH3 (0.33) HRH3
SCHEMBL26743246 0.83 HRH3 (0.31) HRH3
SCHEMBL24185489 0.82 HRH3 (0.37) HRH3
SCHEMBL29316812 0.82 HRH3 (0.45) HRH3
SCHEMBL25507528 0.81 HRH3 (0.35) HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023131167-A1 COMPOUND FOR INHIBITING AND DEGRADING IRAK4, AND PHARMACEUTICAL COMPOSITION AND PHARMACEUTICAL APPLICATION THEREOF 海思科医药集团股份有限公司 2023-07-13 WO disclosed